Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.

Psychopharmacology bulletin

Volumn 41, Issue 3, 2008, Pages 51-67

  Dawson, Ree ^a   Green, Alan I ^b   Drake, Robert E ^b   McGlashan, Thomas H ^b   Schanzer, Bella ^b   Lavori, Philip W ^b  

^a FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIPSYCHOTIC AGENTS; HUMANS; MEDICATION ADHERENCE; PSYCHOSES, SUBSTANCE-INDUCED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 78650387893     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)